The Johns Hopkins Melanoma Program sees approximately 400 new patients in its clinics annually, and treats between 250 – 300 cases of newly diagnosed melanoma per year. Our physician-scientists are leaders in studying innovative ways to treat melanoma and find new ways to detect and prevent it. Learn more about our each member of our patient care and research teams.
Melanoma Tumor Board, Johns Hopkins Kimmel Cancer Center
Melanoma Program Leadership:
Suzanne L. Topalian, M.D.
Director, Melanoma Program
William Sharfman, M.D.
Director, Cutaneous Oncology
Timothy Wang, M.D., and Julie Lange, M.D.
Clinical Co-Directors, Melanoma Program